{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:07:28Z","timestamp":1788905248706,"version":"build-2803163510"},"reference-count":116,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Medical University of Bialystok","doi-asserted-by":"publisher","award":["SUB\/01\/DN\/19\/003\/12\/03"],"award-info":[{"award-number":["SUB\/01\/DN\/19\/003\/12\/03"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.advms.2023.02.003","type":"journal-article","created":{"date-parts":[[2023,3,12]],"date-time":"2023-03-12T06:33:30Z","timestamp":1678602810000},"page":"111-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Genome-engineering technologies for modeling and treatment of cystic fibrosis"],"prefix":"10.1016","volume":"68","author":[{"given":"Micha\u0142","family":"D\u0119bczy\u0144ski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Mojsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Minarowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Maciejewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Lisowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Mr\u00f3z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2023.02.003_bib1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jcf.2008.03.007","article-title":"The prevalence of cystic fibrosis in the European Union","volume":"7","author":"Farrell","year":"2008","journal-title":"J\u00a0Cyst Fibros"},{"issue":"245","key":"10.1016\/j.advms.2023.02.003_bib2","first-page":"1066","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"1989","author":"Riordan","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.advms.2023.02.003_bib3","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O'Sullivan","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.advms.2023.02.003_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ppul.20147","article-title":"CFTR: more than just a chloride channel","volume":"39","author":"Mehta","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.advms.2023.02.003_bib6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","article-title":"From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations","volume":"27","author":"Veit","year":"2016","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.advms.2023.02.003_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jcf.2013.12.003","article-title":"The relative frequency of CFTR mutation classes in European patients with cystic fibrosis","volume":"13","author":"de Boeck","year":"2014","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.advms.2023.02.003_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/humu.10041","article-title":"Cystic fibrosis: a worldwide analysis of CFTR mutations\u2014correlation with incidence data and application to screening","volume":"19","author":"Bobadilla","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1016\/j.advms.2023.02.003_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.12.032","article-title":"A\u00a0therapy for most with cystic fibrosis","volume":"180","author":"Bear","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.advms.2023.02.003_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2013.00040","article-title":"Genetic influences on cystic fibrosis lung disease severity","volume":"4","author":"Weiler","year":"2013","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.advms.2023.02.003_bib11","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1378\/chest.07-0288","article-title":"Sodium channels and cystic fibrosis","volume":"132","author":"Donaldson","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.advms.2023.02.003_bib12","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00196314","article-title":"Future trends in cystic fibrosis demography in 34 European countries","volume":"46","author":"Burgel","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.advms.2023.02.003_bib13","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.advms.2023.02.003_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199573","article-title":"A\u00a0G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies","volume":"13","author":"McHugh","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.advms.2023.02.003_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113903","article-title":"Gene therapy for cystic fibrosis: progress and challenges of genome editing","volume":"21","author":"Maule","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.advms.2023.02.003_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1152\/physiol.00041.2016","article-title":"In vitro models to study human lung development, disease and homeostasis","volume":"32","author":"Miller","year":"2017","journal-title":"Physiology"},{"key":"10.1016\/j.advms.2023.02.003_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96565-4","article-title":"Functional human iPSC-derived alveolar-like cells cultured in a miniaturized 96-Transwell air\u2013liquid interface model","volume":"11","author":"Bluhmki","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.advms.2023.02.003_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s11626-020-00517-7","article-title":"Invited review: human air-liquid-interface organotypic airway tissue models derived from primary tracheobronchial epithelial cells\u2014overview and perspectives","volume":"57","author":"Cao","year":"2021","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"10.1016\/j.advms.2023.02.003_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113901","article-title":"Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics","volume":"176","author":"Artzy-Schnirman","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.advms.2023.02.003_bib20","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1021\/acsbiomaterials.1c00306","article-title":"Airway and Alveoli organoids as valuable research tools in COVID-19","volume":"7","author":"de Oliveira","year":"2021","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.advms.2023.02.003_bib21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/ncb3510","article-title":"A\u00a0three-dimensional model of human lung development and disease from pluripotent stem cells","volume":"19","author":"Chen","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.advms.2023.02.003_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.709183","article-title":"Human embryos, induced pluripotent stem cells, and organoids: models to assess the effects of environmental plastic pollution","volume":"9","author":"Miloradovic","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.advms.2023.02.003_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99815-7","article-title":"In vitro impact preliminary assessment of airborne particulate from metalworking and woodworking industries","volume":"11","author":"Pavlovska","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.advms.2023.02.003_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/nrd.2016.245","article-title":"Induced pluripotent stem cell technology: a decade of progress","volume":"16","author":"Shi","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.advms.2023.02.003_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.advms.2023.02.003_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2014.07.005","article-title":"Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells","volume":"3","author":"Gotoh","year":"2014","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.advms.2023.02.003_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2020.09.017","article-title":"Derivation of airway basal stem cells from human pluripotent stem cells","volume":"28","author":"Hawkins","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.advms.2023.02.003_bib28","article-title":"Stage-specific generation of human pluripotent stem cell derived lung models to measure CFTR function","volume":"2","author":"Ngan","year":"2022","journal-title":"Curr Protoc"},{"key":"10.1016\/j.advms.2023.02.003_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.scr.2018.03.004","article-title":"Generation of two induced pluripotent stem cell (iPSC) lines from p.F508del Cystic Fibrosis patients","volume":"29","author":"Fleischer","year":"2018","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.advms.2023.02.003_bib30","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41596-018-0104-8","article-title":"Generation of lung organoids from human pluripotent stem cells in vitro","volume":"14","author":"Miller","year":"2019","journal-title":"Nat Protoc"},{"key":"10.1016\/j.advms.2023.02.003_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2020.04.005","article-title":"iPSC-Derived Intestinal Organoids from Cystic Fibrosis Patients Acquire CFTR Activity upon TALEN-Mediated Repair of the p.F508del Mutation","volume":"17","author":"Fleischer","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.advms.2023.02.003_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.24118","article-title":"Induced pluripotent stem cells for treating cystic fibrosis: state of the science","volume":"53","author":"Pollard","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.advms.2023.02.003_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.662110","article-title":"On the corner of models and cure: gene editing in cystic fibrosis","volume":"12","author":"Ensinck","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.advms.2023.02.003_bib34","doi-asserted-by":"crossref","DOI":"10.1089\/hum.2020.160","article-title":"Correction of airway stem cells: genome editing approaches for the treatment of cystic fibrosis","volume":"31","author":"King","year":"2020","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.advms.2023.02.003_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2019.04.014","article-title":"High-throughput screening for modulators of CFTR activity based on genetically engineered cystic fibrosis disease-specific iPSCs","volume":"12","author":"Merkert","year":"2019","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.advms.2023.02.003_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad8278","article-title":"Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis","volume":"8","author":"Dekkers","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.advms.2023.02.003_bib37","first-page":"13","article-title":"Pharmacological modulation of ion channels for the treatment of cystic fibrosis","author":"Pinto","year":"2021","journal-title":"J\u00a0Exp Pharmacol"},{"key":"10.1016\/j.advms.2023.02.003_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddy186","article-title":"Drug screening for human genetic diseases using iPSC models","volume":"27","author":"Elitt","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.advms.2023.02.003_bib39","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.molmed.2018.06.009","article-title":"Pluripotent stem-cell platforms for drug discovery","volume":"24","author":"Chen","year":"2018","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.advms.2023.02.003_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102207","article-title":"Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery","volume":"53","author":"Giani","year":"2021","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.advms.2023.02.003_bib41","article-title":"Advanced in vitro lung models for drug and toxicity screening: the promising role of induced pluripotent stem cells","volume":"6","author":"Moreira","year":"2022","journal-title":"Adv Biol"},{"key":"10.1016\/j.advms.2023.02.003_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123419","article-title":"High-throughput functional analysis of CFTR and other apically localized proteins in iPSC-derived human intestinal organoids","volume":"10","author":"Xia","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.advms.2023.02.003_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/jb.169.12.5429-5433.1987","article-title":"Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isoenzyme conversion in Escherichia coli, and identification of the gene product","volume":"169","author":"Ishino","year":"1987","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.advms.2023.02.003_bib44","first-page":"337","article-title":"A\u00a0programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"2012","author":"Jinek","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.advms.2023.02.003_bib45","first-page":"315","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"2007","author":"Barrangou","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.advms.2023.02.003_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/sj.embor.7400325","article-title":"RNA sequence- and shape-dependent recognition by proteins in the ribonucleoprotein particle","volume":"6","author":"Stefl","year":"2005","journal-title":"EMBO Rep"},{"key":"10.1016\/j.advms.2023.02.003_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.tim.2016.06.005","article-title":"On the origin of CRISPR-cas technology: from prokaryotes to mammals","volume":"24","author":"Mojica","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.advms.2023.02.003_bib48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1165\/rcmb.2016-0301PS","article-title":"Gene editing and genetic lung disease basic research meets therapeutic application","volume":"56","author":"Alapati","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.advms.2023.02.003_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-019-0299-x","article-title":"Evolutionary classification of CRISPR\u2013Cas systems: a burst of class 2 and derived variants","volume":"18","author":"Makarova","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.advms.2023.02.003_bib50","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1134\/S0006297922080090","article-title":"CRISPR\u2013Cas9: a history of its discovery and ethical Considerations of its use in genome editing","volume":"87","author":"Gostimskaya","year":"2022","journal-title":"Biochemistry (Moscow)"},{"key":"10.1016\/j.advms.2023.02.003_bib51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1126\/science.abb1400","article-title":"CRISPR-Cas\u03a6 from huge phages is a hypercompact genome editor","volume":"369","author":"Pausch","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.advms.2023.02.003_bib52","first-page":"339","article-title":"RNA-guided human genome engineering via Cas9","volume":"2013","author":"Mali","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.advms.2023.02.003_bib53","article-title":"DNA double strand break repair via non-homologous end-joining","volume":"2","author":"Davis","year":"2013","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.advms.2023.02.003_bib54","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41586-018-0686-x","article-title":"Predictable and precise template-free CRISPR editing of pathogenic variants","volume":"563","author":"Shen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.advms.2023.02.003_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/2041-9414-3-9","article-title":"Pathway choice in DNA double strand break repair: observations of a balancing act","volume":"3","author":"Brandsma","year":"2012","journal-title":"Genome Integr"},{"key":"10.1016\/j.advms.2023.02.003_bib56","article-title":"Repair of double-strand breaks induced by CRISPR\u2013Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.advms.2023.02.003_bib57","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.advms.2023.02.003_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.advms.2023.02.003_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.advms.2023.02.003_bib60","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200283","article-title":"A\u00a0homology independent sequence replacement strategy in human cells using a CRISPR nuclease","volume":"11","author":"Danner","year":"2021","journal-title":"Open Biol"},{"key":"10.1016\/j.advms.2023.02.003_bib61","article-title":"Towards better base editing","volume":"4","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.advms.2023.02.003_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21176240","article-title":"CRISPR-Cas9 DNA base-editing and prime-editing","volume":"21","author":"Kantor","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.advms.2023.02.003_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of T to G C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.advms.2023.02.003_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2019.05.008","article-title":"Developing ABEmax-NG with precise targeting and expanded editing scope to model pathogenic splice site mutations in vivo","volume":"15","author":"Huang","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.advms.2023.02.003_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2020.01.019","article-title":"CRISPR-based adenine editors correct nonsense mutations in a cystic fibrosis organoid biobank","volume":"26","author":"Geurts","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.advms.2023.02.003_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.4194","article-title":"Optimized base editors enable efficient editing in cells, organoids and mice","volume":"36","author":"Zafra","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.advms.2023.02.003_bib67","article-title":"Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope","volume":"11","author":"Jiang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.advms.2023.02.003_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.advms.2023.02.003_bib69","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aao4774","article-title":"Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity","volume":"3","author":"Komor","year":"2017","journal-title":"Sci Adv"},{"key":"10.1016\/j.advms.2023.02.003_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/s41556-020-0518-8","article-title":"Increasing the efficiency and targeting range of cytidine base editors through fusion of a single-stranded DNA-binding protein domain","volume":"22","author":"Zhang","year":"2020","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.advms.2023.02.003_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-021-00938-z","article-title":"Efficient C\u2022G-to-G\u2022C base editors developed using CRISPRi screens, target-library analysis, and machine learning","volume":"39","author":"Koblan","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.advms.2023.02.003_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AEM.02666-20","article-title":"A\u00a0CRISPR\/Cas9-Mediated, homology-independent tool developed for targeted genome integration in Yarrowia lipolytica","volume":"87","author":"Cui","year":"2021","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.advms.2023.02.003_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/s10038-017-0352-4","article-title":"In vivo genome editing via the HITI method as a tool for gene therapy","volume":"63","author":"Suzuki","year":"2018","journal-title":"J\u00a0Hum Genet"},{"key":"10.1016\/j.advms.2023.02.003_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-020-0466-1","article-title":"Current trends in gene recovery mediated by the CRISPR-Cas system","volume":"52","author":"Jang","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.advms.2023.02.003_bib75","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcf.2017.11.018","article-title":"Gene editing & stem cells","volume":"17","author":"Harrison","year":"2018","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.advms.2023.02.003_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161072","article-title":"Targeted integration of a super-exon into the CFTR locus leads to functional correction of a cystic fibrosis cell line model","volume":"11","author":"Bednarski","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.advms.2023.02.003_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19136-7","article-title":"Prime editing for functional repair in patient-derived disease models","volume":"11","author":"Schene","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.advms.2023.02.003_bib78","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41434-021-00263-9","article-title":"Prime editing \u2013 an update on the field","volume":"28","author":"Scholefield","year":"2021","journal-title":"Gene Ther"},{"key":"10.1016\/j.advms.2023.02.003_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28442-1","article-title":"Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair","volume":"13","author":"Ferreira da Silva","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.advms.2023.02.003_bib80","article-title":"Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.advms.2023.02.003_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21337-7","article-title":"PrimeDesign software for rapid and simplified design of prime editing guide RNAs","volume":"12","author":"Hsu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.advms.2023.02.003_bib82","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41551-020-00622-8","article-title":"A\u00a0web tool for the design of prime-editing guide RNAs","volume":"5","author":"Chow","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.advms.2023.02.003_bib83","doi-asserted-by":"crossref","unstructured":"Morris JA, Rahman JA, Guo X, Sanjana NE. Automated design of CRISPR prime editors for thousands of human pathogenic variants n.d. https:\/\/doi.org\/10.1101\/2020.05.07.083444.","DOI":"10.1101\/2020.05.07.083444"},{"key":"10.1016\/j.advms.2023.02.003_bib84","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-021-04034-6","article-title":"PnB Designer: a web application to design prime and base editor guide RNAs for animals and plants","volume":"22","author":"Siegner","year":"2021","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.advms.2023.02.003_bib85","doi-asserted-by":"crossref","DOI":"10.1021\/acssynbio.0c00445","article-title":"Prime editing guide RNA design automation using PINE-CONE","volume":"10","author":"Standage-Beier","year":"2021","journal-title":"ACS Synth Biol"},{"issue":"2","key":"10.1016\/j.advms.2023.02.003_bib86","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41587-020-0677-y","article-title":"Predicting the efficiency of prime editing guide RNAs in human cells","volume":"39","author":"Kim","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.advms.2023.02.003_bib87","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab319","article-title":"PE-Designer and PE-analyzer: web-based design and analysis tools for CRISPR prime editing","volume":"49","author":"Hwang","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.advms.2023.02.003_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-021-02458-0","article-title":"Easy-Prime: a machine learning\u2013based prime editor design tool","volume":"22","author":"Li","year":"2021","journal-title":"Genome Biol"},{"key":"10.1016\/j.advms.2023.02.003_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2021.02.022","article-title":"Engineered prime editors with PAM flexibility","volume":"29","author":"Kweon","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.advms.2023.02.003_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2021.07.011","article-title":"Dual-AAV delivering split prime editor system for in vivo genome editing","volume":"30","author":"Zhi","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.advms.2023.02.003_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2021.786893","article-title":"piggyPrime: high-efficacy prime editing in human cells using piggyBac-based DNA transposition","volume":"3","author":"Wolff","year":"2021","journal-title":"Front Genome Ed"},{"key":"10.1016\/j.advms.2023.02.003_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-021-01025-z","article-title":"Precise genomic deletions using paired prime editing","volume":"40","author":"Choi","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.advms.2023.02.003_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-021-01026-y","article-title":"Deletion and replacement of long genomic sequences using prime editing","volume":"40","author":"Jiang","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.advms.2023.02.003_bib94","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000940","article-title":"Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids","volume":"4","author":"Geurts","year":"2021","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.advms.2023.02.003_bib95","first-page":"33","article-title":"Editorial: genome editing to treat cystic fibrosis and other pulmonary diseases","author":"Vaidyanathan","year":"2022","journal-title":"Front Genome Ed"},{"key":"10.1016\/j.advms.2023.02.003_bib96","article-title":"Expansion of human airway basal stem cells and their differentiation as 3D tracheospheres","volume":"1576","author":"Hynds","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.advms.2023.02.003_bib97","doi-asserted-by":"crossref","DOI":"10.1080\/01902148.2017.1395931","article-title":"Gene therapy for Cystic Fibrosis: improved delivery techniques and conditioning with lysophosphatidylcholine enhance lentiviral gene transfer in mouse lung airways","volume":"43","author":"Cmielewski","year":"2017","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.advms.2023.02.003_bib98","article-title":"CRISPR\/Cas9 gene editing therapies for cystic fibrosis","volume":"21","author":"Graham","year":"2021","journal-title":"Expet Opin Biol Ther"},{"key":"10.1016\/j.advms.2023.02.003_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2019.11.002","article-title":"High-efficiency, selection-free gene repair in airway stem cells from cystic fibrosis patients rescues CFTR function in differentiated epithelia","volume":"26","author":"Vaidyanathan","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.advms.2023.02.003_bib100","article-title":"AAV vector immunogenicity in humans: a long journey to successful gene transfer","volume":"28","author":"Verdera","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.advms.2023.02.003_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/biom10060839","article-title":"Recent advances in CRISPR\/Cas9 delivery strategies","volume":"10","author":"Yip","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.advms.2023.02.003_bib102","volume":"16","author":"Harrison","year":"2022"},{"key":"10.1016\/j.advms.2023.02.003_bib103","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: a review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv"},{"key":"10.1016\/j.advms.2023.02.003_bib104","volume":"12","author":"Chen","year":"2020"},{"key":"10.1016\/j.advms.2023.02.003_bib105","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nbt.4005","article-title":"Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing","volume":"35","author":"Yin","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.advms.2023.02.003_bib106","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.omtm.2019.02.008","article-title":"Advancements and obstacles of CRISPR-cas9 technology in translational research","volume":"13","author":"You","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.advms.2023.02.003_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/v11010028","article-title":"Viral delivery systems for CRISPR","volume":"11","author":"Xu","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.advms.2023.02.003_bib108","article-title":"Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments","volume":"17","author":"Guggino","year":"2017","journal-title":"Expet Opin Biol Ther"},{"key":"10.1016\/j.advms.2023.02.003_bib109","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ymthe.2021.10.023","article-title":"AAV5 delivery of CRISPR-Cas9 supports effective genome editing in mouse lung airway","volume":"30","author":"Liang","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.advms.2023.02.003_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2021.12.003","article-title":"AAV-mediated gene editing lights up the lung","volume":"30","author":"Yan","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.advms.2023.02.003_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.1368","article-title":"Single-dose lentiviral gene transfer for lifetime airway gene expression","volume":"11","author":"Stocker","year":"2009","journal-title":"J\u00a0Gene Med"},{"key":"10.1016\/j.advms.2023.02.003_bib112","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/mt.2010.13","article-title":"Toward gene therapy for cystic fibrosis using a Lentivirus pseudotyped with sendai virus envelopes","volume":"18","author":"Mitomo","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.advms.2023.02.003_bib113","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-021-00662-w","article-title":"Potential of helper-dependent Adenoviral vectors in CRISPR-cas9-mediated lung gene therapy","volume":"11","author":"Bandara","year":"2021","journal-title":"Cell Biosci"},{"key":"10.1016\/j.advms.2023.02.003_bib114","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/acsnano.6b04261","article-title":"Artificial virus delivers CRISPR-cas9 system for genome editing of cells in mice","volume":"11","author":"Li","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.advms.2023.02.003_bib115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.advms.2023.02.003_bib116","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.advms.2023.02.003_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2020.06.001","article-title":"Inhalation delivery technology for genome-editing of respiratory diseases","volume":"168","author":"Chow","year":"2021","journal-title":"Adv Drug Deliv Rev"}],"updated-by":[{"DOI":"10.1016\/j.advms.2025.01.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000}}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S189611262300007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S189611262300007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:44:22Z","timestamp":1761824662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S189611262300007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S189611262300007X"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2023.02.003","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genome-engineering technologies for modeling and treatment of cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2023.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}